BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28971370)

  • 1. Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine.
    Liu Y; Tamam H; Yeo Y
    AAPS PharmSciTech; 2018 Feb; 19(2):693-699. PubMed ID: 28971370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
    Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M
    Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody fragment-conjugated gemcitabine and paclitaxel-based liposome for effective therapeutic efficacy in pancreatic cancer.
    Yang W; Hu Q; Xu Y; Liu H; Zhong L
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():328-335. PubMed ID: 29752104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new therapeutic combination for osteosarcoma: Gemcitabine and Clofazimine co-loaded liposomal formulation.
    Caliskan Y; Dalgic AD; Gerekci S; Gulec EA; Tezcaner A; Ozen C; Keskin D
    Int J Pharm; 2019 Feb; 557():97-104. PubMed ID: 30586631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
    Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.
    Larson N; Yang J; Ray A; Cheney DL; Ghandehari H; Kopeček J
    Int J Pharm; 2013 Sep; 454(1):435-43. PubMed ID: 23827653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Liposomal Gemcitabine with High Drug Loading Capacity.
    Tamam H; Park J; Gadalla HH; Masters AR; Abdel-Aleem JA; Abdelrahman SI; Abdelrahman AA; Lyle LT; Yeo Y
    Mol Pharm; 2019 Jul; 16(7):2858-2871. PubMed ID: 31136710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer.
    Liang Y; Tian B; Zhang J; Li K; Wang L; Han J; Wu Z
    Int J Nanomedicine; 2017; 12():1699-1715. PubMed ID: 28280336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermosensitive and biodegradable hydrogel encapsulating targeted nanoparticles for the sustained co-delivery of gemcitabine and paclitaxel to pancreatic cancer cells.
    Shabana AM; Kambhampati SP; Hsia RC; Kannan RM; Kokkoli E
    Int J Pharm; 2021 Jan; 593():120139. PubMed ID: 33278494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy.
    Sun J; Chen Y; Xu J; Song X; Wan Z; Du Y; Ma W; Li X; Zhang L; Li S
    Theranostics; 2020; 10(3):1136-1150. PubMed ID: 31938056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
    Tang Z; Feng W; Yang Y; Wang Q
    Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy.
    Sun J; Wan Z; Chen Y; Xu J; Luo Z; Parise RA; Diao D; Ren P; Beumer JH; Lu B; Li S
    Acta Biomater; 2020 Apr; 106():289-300. PubMed ID: 32004652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel and gemcitabine combinational drug-loaded mucoadhesive delivery system in the treatment of colon cancers.
    Guo XY; Wang P; Du QG; Han S; Zhu SM; Lv YF; Liu GS; Hao ZM
    Drug Res (Stuttg); 2015 Apr; 65(4):199-204. PubMed ID: 24941086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma.
    Sun L; Zhou DS; Zhang P; Li QH; Liu P
    Int J Pharm; 2015 Jan; 478(1):308-317. PubMed ID: 25433201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Backbone Degradable N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates with Gemcitabine and Paclitaxel: Impact of Molecular Weight on Activity toward Human Ovarian Carcinoma Xenografts.
    Yang J; Zhang R; Pan H; Li Y; Fang Y; Zhang L; Kopeček J
    Mol Pharm; 2017 May; 14(5):1384-1394. PubMed ID: 28094954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A NAG-Guided Nano-Delivery System for Redox- and pH-Triggered Intracellularly Sequential Drug Release in Cancer Cells.
    Liang Y; Zhang J; Tian B; Wu Z; Svirskis D; Han J
    Int J Nanomedicine; 2020; 15():841-855. PubMed ID: 32103941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Long-Circulating and Fusogenic Liposomes Co-encapsulating Paclitaxel and Doxorubicin in Synergistic Ratio for the Treatment of Breast Cancer.
    Roque MC; Franco MS; Vilela JMC; Andrade MS; de Barros ALB; Leite EA; Oliveira MC
    Curr Drug Deliv; 2019; 16(9):829-838. PubMed ID: 31622204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.
    Konecny G; Untch M; Slamon D; Beryt M; Kahlert S; Felber M; Langer E; Lude S; Hepp H; Pegram M
    Breast Cancer Res Treat; 2001 Jun; 67(3):223-33. PubMed ID: 11561768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The construction and characterization of hybrid paclitaxel-in-micelle-in-liposome systems for enhanced oral drug delivery.
    Li Y; Chen Z; Cui Y; Zhai G; Li L
    Colloids Surf B Biointerfaces; 2017 Dec; 160():572-580. PubMed ID: 29028605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.